 |
153 Diseases |  |
74 Trials |
|
74 Trials |  |
10107 News |  |
| «12...74757677787980818283848586» |
- || abiraterone acetate / Generic mfg., docetaxel / Generic mfg.
Trial primary completion date: A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer (clinicaltrials.gov) - Dec 30, 2014
P2, N=82, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
Trial primary completion date: Sep 2014 --> Sep 2015
- Trial completion: Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma (clinicaltrials.gov) - Dec 7, 2014
P2, N=47, Completed, Sponsor: University College, London
Trial primary completion date: Sep 2014 --> Sep 2015 Recruiting --> Completed
- || vigabatrin / Generic mfg.
New P3 trial: PREDVGB: Prednisolone Versus Vigabatrin in the First-line Treatment of Infantile Spasms (clinicaltrials.gov) - Nov 24, 2014
P3, N=105, Not yet recruiting, Sponsor: The Hospital for Sick Children
- prednisolone / Generic mfg.
New P2 trial, Combination therapy: COBS: Efficacy of Combination Therapy of Glucocorticoids and Bovine Colostrum in Treatment of Severe Alcoholic Hepatitis. (clinicaltrials.gov) - Oct 17, 2014
P2, N=10, Not yet recruiting, Sponsor: Dayanand Medical College and Hospital
- bortezomib / Generic mfg.
Trial completion, Enrollment change: Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (clinicaltrials.gov) - Oct 17, 2014
P2, N=50, Completed, Sponsor: Plymouth Hospitals NHS Trust
Recruiting --> Completed Active, not recruiting --> Completed | N=90 --> 50
- ||||| Enrollment closed: Velcade (Bortezomib) Consolidation After Transplant (clinicaltrials.gov) - Oct 2, 2014
P3, N=247, Active, not recruiting, Sponsor: Janssen Scientific Affairs, LLC
Active, not recruiting --> Completed | N=90 --> 50 Recruiting --> Active, not recruiting
- |||| hydrocortisone / Generic mfg.
Enrollment open: Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus (clinicaltrials.gov) - Sep 19, 2014
P2, N=100, Recruiting, Sponsor: US Oncology Research
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||||| hydrocortisone / Generic mfg.
New P2 trial: Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus (clinicaltrials.gov) - Aug 29, 2014
P2, N=100, Not yet recruiting, Sponsor: US Oncology Research
- prednisolone / Generic mfg.
New P2 trial: Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy (clinicaltrials.gov) - Jun 19, 2014
P2, N=24, Recruiting, Sponsor: Washington University School of Medicine
- bortezomib / Generic mfg.
Enrollment closed: Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (clinicaltrials.gov) - Jun 1, 2014
P2, N=90, Active, not recruiting, Sponsor: Plymouth Hospitals NHS Trust
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||| montelukast / Generic mfg.
Enrollment change: Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma (clinicaltrials.gov) - May 11, 2014
P2, N=130, Completed, Sponsor: The Hospital for Sick Children
Recruiting --> Active, not recruiting N=190 --> 130
- |||| montelukast / Generic mfg.
Trial completion: Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma (clinicaltrials.gov) - May 11, 2014
P2, N=130, Completed, Sponsor: The Hospital for Sick Children
N=190 --> 130 Recruiting --> Completed
- |||||| Xofigo (radium Ra-223 dichloride) / Bayer
Enrollment open: ERA 223: Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms (clinicaltrials.gov) - Apr 7, 2014
P3, N=800, Recruiting, Sponsor: Bayer
Recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| Xofigo (radium Ra-223 dichloride) / Bayer
New P3 trial: ERA 223: Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms (clinicaltrials.gov) - Jan 21, 2014
P3, N=800, Recruiting, Sponsor: Bayer
- ||||| Enrollment closed: Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma (clinicaltrials.gov) - Oct 7, 2013
P3, N=393, Active, not recruiting, Sponsor: Children's Oncology Group
Not yet recruiting --> Recruiting Completed --> Active, not recruiting
- | abiraterone acetate / Generic mfg.
Enrollment closed: A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer (clinicaltrials.gov) - Sep 25, 2013
P2, N=48, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
Completed --> Active, not recruiting Recruiting --> Active, not recruiting
- ||||| betamethasone/dexchlorpheniramine maleate / Generic mfg., prednisolone / Generic mfg.
Trial initiation date: Comparison of Desloratadine Associated With Prednisolone (Tablet)Versus Dexchlorpheniramine Associated With Betamethasone (Tablet) for Adult Persistent Allergic Rhinitis Treatment (clinicaltrials.gov) - Sep 23, 2013
P3, N=234, Not yet recruiting, Sponsor: EMS
Recruiting --> Active, not recruiting Initiation date: May 2013 --> Oct 2013
- ||||| betamethasone/dexchlorpheniramine maleate / Generic mfg., prednisolone / Generic mfg.
Trial initiation date: Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment (clinicaltrials.gov) - Sep 23, 2013
P3, N=140, Not yet recruiting, Sponsor: EMS
Initiation date: May 2013 --> Oct 2013 Initiation date: Jun 2013 --> Oct 2013
- ||||| betamethasone/dexchlorpheniramine maleate / Generic mfg., prednisolone / Generic mfg.
Trial initiation date: Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis Treatment (clinicaltrials.gov) - Sep 23, 2013
P3, N=210, Not yet recruiting, Sponsor: EMS
Initiation date: Jun 2013 --> Oct 2013 Initiation date: Jun 2013 --> Oct 2013
- propranolol / Generic mfg.
Trial termination: Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH) (clinicaltrials.gov) - Jul 21, 2013
P2, N=9, Terminated, Sponsor: Seattle Children's Hospital
Initiation date: Jun 2013 --> Oct 2013 Active, not recruiting --> Terminated; Insufficient enrollment
- propranolol / Generic mfg.
Enrollment change: Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH) (clinicaltrials.gov) - Jul 21, 2013
P2, N=9, Terminated, Sponsor: Seattle Children's Hospital
Active, not recruiting --> Terminated; Insufficient enrollment N=60 --> 9
- | Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
New P4 trial: Infliximab Top-down in Pediatric Crohn (clinicaltrials.gov) - Jun 16, 2013
P4, N=90, Enrolling by invitation, Sponsor: Erasmus Medical Center
- prednisolone / Generic mfg., vincristine / Generic mfg.
Trial termination: Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas (clinicaltrials.gov) - Jun 3, 2013
P2, N=8, Terminated, Sponsor: Medical College of Wisconsin
N=60 --> 9 Active, not recruiting --> Terminated; The introduction of oral propranolol as a highly efficacious agent for infantile hemangiomas
- abiraterone acetate / Generic mfg., docetaxel / Generic mfg.
Enrollment closed: A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer (clinicaltrials.gov) - May 30, 2013
P2, N=82, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
Active, not recruiting --> Terminated; The introduction of oral propranolol as a highly efficacious agent for infantile hemangiomas Recruiting --> Active, not recruiting
- Trial withdrawal: Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia (clinicaltrials.gov) - May 29, 2013
P=N/A, N=0, Withdrawn, Sponsor: Children's Oncology Group
Recruiting --> Active, not recruiting Completed --> Withdrawn
- Enrollment change: Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia (clinicaltrials.gov) - May 29, 2013
P=N/A, N=0, Withdrawn, Sponsor: Children's Oncology Group
Completed --> Withdrawn N=100 --> 0
- | prednisolone / Generic mfg.
Trial completion: Prednisolone in Infantile Spasms- High Dose Versus Usual Dose (clinicaltrials.gov) - Apr 6, 2013
P3, N=63, Completed, Sponsor: Lady Hardinge Medical College
N=100 --> 0 Recruiting --> Completed
- | abiraterone acetate / Generic mfg., docetaxel / Generic mfg.
Enrollment change: A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel (clinicaltrials.gov) - Mar 14, 2013
P2, N=47, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
Recruiting --> Completed N=38 --> 47
- | abiraterone acetate / Generic mfg., docetaxel / Generic mfg.
Enrollment closed: A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel (clinicaltrials.gov) - Mar 14, 2013
P2, N=47, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
N=38 --> 47 Recruiting --> Active, not recruiting
- | abiraterone acetate / Generic mfg., docetaxel / Generic mfg.
New P2 trial: A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel (clinicaltrials.gov) - Feb 19, 2013
P2, N=47, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
- prednisolone / Generic mfg.
Trial completion: ProCort1: Progression of HIV-Disease Under Low Dose Corticosteroids (clinicaltrials.gov) - Feb 6, 2013
P2, N=326, Completed, Sponsor: Medical Mission Institute, Germany
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- prednisolone / Generic mfg.
Enrollment change: Immune Suppression Of Infants Treated With Steroids (clinicaltrials.gov) - Jan 22, 2013
P=N/A, N=16, Completed, Sponsor: Medical College of Wisconsin
Active, not recruiting --> Completed N=20 --> 16
- prednisolone / Generic mfg.
Trial completion: Immune Suppression Of Infants Treated With Steroids (clinicaltrials.gov) - Jan 22, 2013
P=N/A, N=16, Completed, Sponsor: Medical College of Wisconsin
N=20 --> 16 Active, not recruiting --> Completed
- |||||| abiraterone acetate / Generic mfg.
Enrollment open: Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer (clinicaltrials.gov) - Jan 10, 2013
P3, N=5000, Recruiting, Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Active, not recruiting --> Completed Available --> Recruiting
- ||||| tacrolimus intravenous / Generic mfg.
New P4 trial, Combination therapy: T-OPTIMUM: A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome (clinicaltrials.gov) - Jan 7, 2013
P4, N=152, Recruiting, Sponsor: Astellas Pharma Korea, Inc.
- prednisolone / Generic mfg.
New P2 trial: Glucocorticoid Induced Whole Body Catabolisme (clinicaltrials.gov) - Jan 3, 2013
P2, N=20, Recruiting, Sponsor: University of Aarhus
- | abiraterone acetate / Generic mfg.
New P2 trial: A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer (clinicaltrials.gov) - Dec 25, 2012
P2, N=48, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
- || prednisolone / Generic mfg., fluticasone / Generic mfg.
New P3 trial: Management of Recurrent Croup (clinicaltrials.gov) - Dec 10, 2012
P3, N=100, Recruiting, Sponsor: University of Michigan
- | pentoxifylline / Generic mfg.
Enrollment change: Efficacy of Pentoxifylline on Primary Nephrotic Syndrome (clinicaltrials.gov) - Nov 11, 2012
P3, N=62, Completed, Sponsor: National Taiwan University Hospital
Available --> Recruiting N=120 --> 62
- | pentoxifylline / Generic mfg.
Trial completion: Efficacy of Pentoxifylline on Primary Nephrotic Syndrome (clinicaltrials.gov) - Nov 11, 2012
P3, N=62, Completed, Sponsor: National Taiwan University Hospital
N=120 --> 62 Recruiting --> Completed
- |||||||||| betamethasone/dexchlorpheniramine maleate / Generic mfg., prednisolone / Generic mfg.
New P3 trial: Comparison of Desloratadine Associated With Prednisolone (Tablet)Versus Dexchlorpheniramine Associated With Betamethasone (Tablet) for Adult Persistent Allergic Rhinitis Treatment (clinicaltrials.gov) - Oct 31, 2012
P3, N=234, Not yet recruiting, Sponsor: EMS
- prednisolone / Generic mfg., mycophenolate mofetil / Generic mfg.
Enrollment open: Astronef: Absence of Steroid in Renal Transplantation and Digital Fibrosis Observation (clinicaltrials.gov) - Oct 17, 2012
P4, N=186, Recruiting, Sponsor: Nantes University Hospital
Recruiting --> Completed Not yet recruiting --> Recruiting
- Depocyte (liposomal cytarabine) / Mundipharma, Leadiant Biosci
Trial suspension: Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL) (clinicaltrials.gov) - Oct 5, 2012
P3, N=100, Suspended, Sponsor: Nordic Society for Pediatric Hematology and Oncology
Not yet recruiting --> Recruiting Recruiting --> Suspended
- |||| prednisone / Generic mfg., abiraterone acetate / Generic mfg., docetaxel / Generic mfg.
Trial completion: An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy (clinicaltrials.gov) - Oct 2, 2012
P2, N=58, Completed, Sponsor: Cougar Biotechnology, Inc.
Recruiting --> Suspended Active, not recruiting --> Completed
- | abiraterone acetate / Generic mfg., docetaxel / Generic mfg.
New P2 trial: A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer (clinicaltrials.gov) - Sep 13, 2012
P2, N=82, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
- sirolimus / Generic mfg.
New P2 trial: Rapamune Improves Outcomes of Severe H1N1 Pneumonia (clinicaltrials.gov) - Jun 13, 2012
P2, N=38, Completed, Sponsor: Chang Gung Memorial Hospital
- | prednisolone / Generic mfg.
Trial initiation date: TryCort: Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis (clinicaltrials.gov) - May 22, 2012
P2/3, N=130, Enrolling by invitation, Sponsor: Rheumazentrum Ruhrgebiet
Active, not recruiting --> Completed Initiation date: Oct 2011 --> Feb 2012
- | prednisolone / Generic mfg.
Enrollment open: TryCort: Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis (clinicaltrials.gov) - May 22, 2012
P2/3, N=130, Enrolling by invitation, Sponsor: Rheumazentrum Ruhrgebiet
Initiation date: Oct 2011 --> Feb 2012 Not yet recruiting --> Enrolling by invitation
- Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Trial termination, Monotherapy: MUNIX: Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553) (clinicaltrials.gov) - Apr 17, 2012
P3, N=28, Terminated, Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting --> Enrolling by invitation Completed --> Terminated; Due to slow recruitment the study was stopped prematurely.
- Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Enrollment change, Monotherapy: MUNIX: Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553) (clinicaltrials.gov) - Apr 17, 2012
P3, N=28, Terminated, Sponsor: Merck Sharp & Dohme Corp.
Completed --> Terminated; Due to slow recruitment the study was stopped prematurely. N=400 --> 28